1. Home
  2. AAME vs NKGN Comparison

AAME vs NKGN Comparison

Compare AAME & NKGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAME
  • NKGN
  • Stock Information
  • Founded
  • AAME 1968
  • NKGN 2017
  • Country
  • AAME United States
  • NKGN United States
  • Employees
  • AAME N/A
  • NKGN N/A
  • Industry
  • AAME Life Insurance
  • NKGN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AAME Finance
  • NKGN Health Care
  • Exchange
  • AAME Nasdaq
  • NKGN Nasdaq
  • Market Cap
  • AAME 34.9M
  • NKGN 24.1M
  • IPO Year
  • AAME N/A
  • NKGN N/A
  • Fundamental
  • Price
  • AAME $1.62
  • NKGN $1.28
  • Analyst Decision
  • AAME
  • NKGN
  • Analyst Count
  • AAME 0
  • NKGN 0
  • Target Price
  • AAME N/A
  • NKGN N/A
  • AVG Volume (30 Days)
  • AAME 3.2K
  • NKGN 2.2M
  • Earning Date
  • AAME 08-06-2024
  • NKGN 08-16-2024
  • Dividend Yield
  • AAME 2.45%
  • NKGN N/A
  • EPS Growth
  • AAME N/A
  • NKGN N/A
  • EPS
  • AAME N/A
  • NKGN N/A
  • Revenue
  • AAME $187,521,000.00
  • NKGN N/A
  • Revenue This Year
  • AAME N/A
  • NKGN N/A
  • Revenue Next Year
  • AAME N/A
  • NKGN N/A
  • P/E Ratio
  • AAME N/A
  • NKGN N/A
  • Revenue Growth
  • AAME 2.74
  • NKGN N/A
  • 52 Week Low
  • AAME $1.49
  • NKGN $0.78
  • 52 Week High
  • AAME $3.00
  • NKGN $6.70
  • Technical
  • Relative Strength Index (RSI)
  • AAME 45.24
  • NKGN 54.52
  • Support Level
  • AAME $1.60
  • NKGN $0.87
  • Resistance Level
  • AAME $1.77
  • NKGN $1.37
  • Average True Range (ATR)
  • AAME 0.07
  • NKGN 0.14
  • MACD
  • AAME 0.01
  • NKGN 0.02
  • Stochastic Oscillator
  • AAME 40.00
  • NKGN 81.64

About AAME Atlantic American Corporation

Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts. It also provides tailored business automobile insurance coverage, on a multi-year contract basis, to state governments and local municipalities, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance. It earns revenue from the collection of premiums and investment income.

About NKGN NKGen Biotech Inc.

NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.

Share on Social Networks: